Drug Safety Issues: Psychotropic Drugs
A Brandeis University study reviewed clinical practice (doctor office visits) and found that drug prescriptions for the treatment of depression, anxiety and mood or attention disorders in teenagers (14 to 18) increased by 250% between 1994-2001.
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
AHRP Testimonies and Presentations Sep 8, 2005: AHRP Testimony: NYS Hearing –AIDS Drug /Vaccine Experiments on Foster Children July 18, 2005: Cheaper than Chimpanzees Statement by Vera Hassner Sharav before the Committee on Ethical Consideration for Revisions to DHHS Regulations on Protection of Prisoners Involved in Research July 2-Â 8, 2005:…
Dying to be Famous? Shooting Fuels Debate Over Safety of Prozac for Teens Sun, 27 Mar 2005 An Op Ed in The New York Times by Lionel Shriver (from London), dismisses the notion promulgated by the mental health industry–which is under the influence of drug companies–that “early signs” in troubled…
January 7, 2002 FYI MAD IN AMERICA (Perseus Press), a new book by Robert Whitaker, a prize winning science journalist, is sure to cause a stir. Whitaker holds psychiatry’s feet to the fire by examining the evidence in the professional psychiatric literature, FDA documents, published treatment outcome studies–including the World…
July 14, 2000. New FDA Warning about fatal risk linked to Melaril after 40 years! FYI For 40 years schizophrenia patients have been prescribed Mellaril, a drug that the FDA finally acknowledges causes sudden death due to cardiac arrest! Why did it take the FDA 40 years before it sent…
Chemically Induced Psychosis Experiments: An Inhumane Paradigm in Psychiatric Research Congressional Testimony submitted by Vera Sharav * February 2, 2000 Statement For the Record Submitted To U.S. Senate Sub-Committee: Public Health & Safety of the Senate Health, Education, Labor & Pensions Committee Hearing Our efforts helped bring to public attention…
Evidence of Neuroleptic Drug-Induced Brain Damage in Patients: A partial, Annotated Bibliography by Vera Hassner Sharav ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) 142 West End Ave. Suite 28P New York, NY 10023 212-595-8974 FAX: 212-595-9086 e-mail: veracare@rcn.com For distribution: January, 2000 Although patients, families and the public were not informed…
